[Lichen sclerosus--clinical and therapeutic aspects]
- PMID: 24919340
[Lichen sclerosus--clinical and therapeutic aspects]
Abstract
Lichen sclerosus (LS) is a lymphocyte-mediated inflammatory dermatosis with a characteristic location (85-98%) in the anogenital region. The authors point out the main features in the epidemiology and clinical presentation of the disease and the possible approach to neoplastic development. Expanded differential diagnosis of LS sparked not only dermatologists but also gynecologists, urologists and GPs. Points are the chronic course of the disease and resistance to therapy. Discuss the results of the treatment of LS with less potent topical corticosteroids, calcineurin inhibitors, phototherapy and photodynamic therapy, surgery.
Similar articles
-
[Lichen sclerosus].Ned Tijdschr Geneeskd. 2007 Jun 2;151(22):1225-31. Ned Tijdschr Geneeskd. 2007. PMID: 17583090 Review. Dutch.
-
[Lichen sclerosus. New aspects of pathogenesis and treatment].Hautarzt. 2005 Jun;56(6):550-5. doi: 10.1007/s00105-005-0955-0. Hautarzt. 2005. PMID: 15889230 Review. German.
-
[Vulvar lichen sclerosus].Rev Med Liege. 2005 Jul-Aug;60(7-8):656-60. Rev Med Liege. 2005. PMID: 16184741 Review. French.
-
Diagnosis and treatment of lichen sclerosus: an update.Am J Clin Dermatol. 2013 Feb;14(1):27-47. doi: 10.1007/s40257-012-0006-4. Am J Clin Dermatol. 2013. PMID: 23329078 Free PMC article. Review.
-
[Lichen sclerosus : Symptoms, diagnosis, therapeutic procedures].Hautarzt. 2018 Feb;69(2):127-133. doi: 10.1007/s00105-017-4121-2. Hautarzt. 2018. PMID: 29340709 Review. German.